Sunday, June 7, 2026 | 6:45 pm - 8:15 pm CT | Hilton Riverside


Supported by an independent educational grant from Dexcom

Type 2 diabetes (T2D) is a progressive, high-burden disease driving cardiovascular, renal, and metabolic complications despite advances in care.

This symposium reframes real-time continuous glucose monitoring (rtCGM) as a proactive tool for wellness and treatment optimization in T2D, reviewing evidence, implementation strategies, team-based care, CGM metrics, access considerations, and case-based applications to support real-world practice.

Join us to translate evidence into actionable strategies for improving outcomes in T2D.

In order to attend in-person, you will need to be a registered attendee of the American Diabetes Association’s 86th Scientific Sessions.
Register Today
Medical Director, JAEB Center for Health Research
Medical Director, International Diabetes Center, Health Partners Institute; Consultant in Internal Medicine, Park Nicollet Clinic
Associate Professor of Family Medicine, University of Colorado Anschutz Medical Campus



Target Audience

This educational activity is intended for an audience of primary care physicians, diabetologists/endocrinologists, physician assistants, nurse practitioners, and nurses in the United States.

Goal Statement

The goal of this activity is for learners to be better able to understand and adopt rtCGM for people with type 2 diabetes (T2D) in clinical practice. 

Learning Objectives

Upon completion of this activity, participants will:

Have increased knowledge regarding the
  • Clinical data supporting the use of rtCGM for T2D
Have greater competence related to
  • The implementation of rtCGM in various patient populations to improve treatment and lifestyle changes
  • The use of rtCGM metrics to adjust treatment using shared decision-making
Demonstrate greater confidence in their ability to
  • Use team-based care to improve rtCGM use